EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its ...

Also complicating matters last year was a dispute with Shanghai biotech Nuance Pharma over a licensing agreement for otenaproxesul in the Greater China region, which resulted in an order for ...

Bavarian Nordic has licensed rights to its respiratory syncytial virus (RSV) vaccine in China and certain other Asian markets to Shanghai's Nuance Pharma in a $225 million deal. The agreement ...

This study is being conducted by Verona's partner in Greater China, Nuance Pharma. Results from the trial are expected in 2025. When we alerted readers to VRNA on May 17, 2024, it was trading at ...